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Abstract
Background—Stroke is the second leading cause of mortality and the leading cause of disability in the
world today. The disease burden is on the rise in developing nations, but there is scarcity of data from these
regions to inform policy decisions. Stroke burden can be determined by clinical diagnosis alone in the pub-
lic health context and is a far more feasible way to assess disease status in low- to middle-income countries
like Pakistan. We aim to translate and adapt a validated stroke symptom questionnaire, train community
health workers in its administration, and verify it against assessment by two trained neurologists.
Methods/Design—This is a prospective study, which we aim to carry out in Ibrahim Hyderi, a periurban
slum of Karachi. We translated into Urdu the questionnaire for verifying stroke free status (QVSFS), which
is an internationally validated tool to assess the same. Two community health workers (CHW) will be iden-
tified and will receive training by neurologists, which will include teaching regarding stroke pathophysiol-
ogy, symptomatology, and detection. They will be familiarized with the QVSFS, and their questionnaire
administration will be assessed through roleplay. We intend to recruit 322 subjects from the same commun-
ity and the CHWs will gather data on them. The same subjects will later be assessed by two trained neurol-
ogists, and the findings collaborated to validate those obtained by the CHWs. Sensitivity, specificity, posi-
tive and negative predictive values, and Cohen’s kappa will be determined for the CHW-administered ques-
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tionnaire tested against assessment by two neurologists together and separately for the two CHWs. Data
analysis will be done using SPSS version 19.0.
Discussion—The results of this study will determine if and how well CHW-administered questionnaires
are at assessing stroke status in a community. This will facilitate use of the same as a practical alternative
for stroke surveillance in the country.
Trial Registration: NCT02073955
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Background
Stroke is the second leading cause of mortality in the
world today after ischemic heart disease, and the leading
cause of disability [1]. In 2005, it caused 5.7 million
deaths worldwide [2]. A recent systematic review of
population-based studies shows a divergent trend in
stroke incidence. It shows a 42% decrease in stroke inci-
dence in high-income countries and a greater than 100%
increase in stroke incidence in low- to middle-income
countries [3]. As the burden of stroke increases with an
increase in ageing population, communities in epidemio-
logical transition, also seem to suffer the brunt of this
change [4]. However, the health system resources
required to counteract this growing burden remain inad-
equate in these countries.
Consistent with this finding, South Asia represents a
quarter of the emerging world and harbors 20% of the
global stroke population [5]. Age-adjusted incident rates
of stroke reported in South Asia are higher (145–262 per
100,000) compared with other developing countries, but
these estimates are mostly derived from Indian studies,
many of which are hospital based [6], [7]. Evidence
from developed countries inform us that almost one
third of stroke patients are never admitted to the hospi-
tal, which adds a huge bias to the estimates relying
solely on this kind of data [8]. The projected increase in
stroke and coronary heart disease (CHD) incidence is
also expected to be much greater in South Asia than in
any other region worldwide, mainly related to demo-
graphic transition [6], [9].
Unfortunately, it is recognized by researchers across the
world that there is a serious lack of sound stroke epi-
demiology data from South Asia, countries that have the
largest share of this chronic condition [9]. As a result,
strategies to prevent, detect, and treat stroke are lacking
in these countries.
Burden of Stroke in Pakistan
Pakistan has a population of over 170 million, and is the
sixth most populous country in the world [10]. There are
no large population-based studies from Pakistan to
determine burden (incidence and prevalence) of stroke
in the community. However, there are data suggesting
high prevalence of vascular risk factors, namely, hyper-
tension, diabetes, obesity, and smoking, among Pakista-
nis and this leads to the assumption that the burden of
stroke is likely to be high as well [11], [12]. In a recent
community-based study carried out in an urban slum of
Pakistan, these risk factors were found to be abundant
and a combination of two or more of these common vas-
cular risk factors increased the odds of having a stroke
significantly [13]. An earlier study had also identified
similar risk factors in a single ethnic community [11].
The annual incidence of stroke is reported to be
250/100,000, translating into 350,000 new cases every
year, although these estimates are not recent [14]. The
more recent community-based study has highlighted the
alarmingly high prevalence of stroke/transient ischemic
attack (TIA) symptoms in this part of the world [15].
Conducted in a periurban slum of Karachi, this study
reported symptoms of stroke or TIA in 21.8% of the
people evaluated. In compared with the existing world-
wide literature on stroke prevalence, this study shows a
lifetime prevalence of stroke that is almost twice the
highest reported prevalence in the world to date [15]. A
prior study reported a stroke prevalence of 4.8% in a sin-
gle ethnic group in Pakistan [11].
These observations suggest a population uniquely at risk
for stroke [16]. Given the increased mortality in this
population from stroke, efforts to inform early detection
of stroke using lay workers may have significant policy
implications for prevention.
The need for Stroke Surveillance
As the rising risk factors like diabetes and hypertension,
demographic transition, and rapid urbanization fuel the
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stroke burden in Pakistan; there is a need to determine
this burden more accurately through surveillance. These
kinds of data are needed for stroke to inform better
resource allocation in resource poor settings and to plan
public health initiatives to reduce the burden of this
important condition.
Unlike most chronic diseases that require access to labo-
ratories and medical specialists for diagnosis, stroke is
amenable to surveillance primarily because its diagnosis
is based on a clinical definition in the public health con-
text [17]. The World Health Organization (WHO) rec-
ommends three steps for determination of stroke burden
in any community [17], [18] (see Figure 1). Step 1 is
hospital-based admission figures. But in countries like
Pakistan, where tertiary care hospitals are few, not all
people have access to them and health seeking behaviors
are inadequate due to low literacy, these figures are not
reliable and are often underestimated.
Step 2 is a community-based fatal stroke event register.
This helps in identifying cases, in which the patient
either did not seek medical care or died before hospitali-
zation. In Pakistan, many deaths go unregistered and the
cause of death is also not accurately documented.
Finally, step 3 is a community-based nonfatal stroke
event register. These may make up a substantial burden
again in a country like Pakistan, where recognition of
disease and access to health care leave much to be
desired. Hence, this may be the best way of investigating
both the incidence and the prevalence of chronic condi-
tions like stroke in countries like Pakistan.
The community-based nonfatal stroke event register
may be the most realistic approach to determining the
Figure 1.  The WHO stepwise approach to stroke surveillance.
 
burden that this debilitating condition poses on our
health system. However, one of the biggest challenges in
implementing this last step and setting up an effective
surveillance system is availability of appropriate valida-
ted tools for detecting stroke in the community.
Stroke Symptom Questionnaires
SSQs have been in use for several decades to screen
individuals for presence of stroke. One such question-
naire was used by investigators of Asymptomatic Caro-
tid Atherosclerosis Study (ACAS), and the Atheroscle-
rosis Risk in Communities (ARIC) study [19], [20].
Another such questionnaire was developed to identify
stroke free phenotype for clinical studies on genetics
[21], [22]. This QVSFS consisted of eight questions, six
of which were related to stroke symptoms, namely, hem-
iplegia, hemianesthesia, hemianopia, loss of vision in
one eye, inability to speak, and inability to understand.
The questionnaire was found to be reliable and valid for
this kind of screening in subsequent studies [22], [23].
Although designed for ascertaining stroke free status, its
six symptoms questions have recently been shown to be
an effective tool for screening for stroke or TIA with a
high sensitivity and moderate specificity [24]. Hence,
these questions have a potential for being used as a pub-
lic health screening instrument for identifying individu-
als with symptomatic stroke.
Validation of most SSQs has been carried out in hospi-
tals or other clinical setups using trained research assis-
tants [21]–[25]. However, when translated in local lan-
guage, using relevant terminology, a similar set of ques-
tions were shown to have an excellent sensitivity in a
community-based validation study in Mexico [26]. The
sensitivity was in the range of 70% when administered
by CHWs in another recent study from Brazil [27].
In a resource poor country like Pakistan, access to terti-
ary care settings is limited for a vast majority of people.
Therefore, a similar SSQ based on commonly reported
stroke symptoms in Pakistani population can help
trained community workers identify community dwell-
ing stroke patients. Once shown to have scientific valid-
ity, these can be implemented with low cost and can
serve as useful instruments for planning local health care
systems for stroke detection and surveillance.
Role of CHW
CHW have been variably defined over the past few dec-
ades. However, all definitions entail a core set of charac-
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teristics. They are individuals who live in the commun-
ity, serve as connectors between health care providers
and the community members and work toward health
promotion in their respective communities [28], [29].
They receive a short defined training and are not neces-
sarily attached to any formal institution [30].
The role of CHWs has evolved tremendously over the
past couple of decades. In developed countries, they
have helped in overcoming barriers to health care for
underserved communities, helped in reducing overall
health care costs and improved self-care of chronic dis-
eases [29]. In developing countries, there has been little
focus on utilizing them for noncommunicable disease
surveillance or interventions [31]. Isfahan Healthy Heart
Program (IHHP) [32], [33] is perhaps, the best example
from this region so far, where community workers have
been trained to assess cardiovascular risk factors with a
goal for primary prevention and improving health
behaviors.
However, other examples like these are hard to find in
the field of noncommunicable diseases. Now, with the
rising burden of these conditions in our part, there is a
strong need to explore the utilization of CHWs in this
area as well.
Gold Standard for Validation
For definitive diagnosis of stroke and also to determine
its subtype, brain imaging is the best available modality.
This includes both computerized tomography (CT) and
magnetic resonance imaging (MRI) of the brain. Ideally,
these should serve as gold standard for stroke diagnosis.
However, there were several reasons why we do not
plan to utilize this gold standard, and instead consider
the opinion of two neurologists based on history and
physical exam as gold standard for our validation study.
First, both CT and MRI carry some risk to the subject,
even though very minimal. Therefore, we cannot justify
their use in subjects with no indication. Since this is a
validation study, there is a need to evaluate both positive
and negative cases using the gold standard for diagnosis.
Second, in the public health context, the definition of
stroke is clinical and not imaging based. According to
WHO, stroke is defined as “a focal (or at times global)
neurological impairment of sudden onset, and lasting
more than 24 hours (or leading to death) and of pre-
sumed vascular origin” [17], [34]. Therefore, using a
clinical diagnosis as gold standard seems appropriate.
Other studies that have validated similar SSQs have all
used a similar gold standard [22], [24]–[27]. None has
utilized imaging to validate their findings. Judging by
this, assessment by neurologist is an accepted gold
standard the world over.
Finally, due to logistic and financial constraints, it does
not seem possible for us to image more than 300 sub-
jects, most of whom do not have stroke symptoms. (See
Figure 2: a framework justifying our selection of gold
standard)
Gaps in Knowledge
With the rising burden of stroke in a transitional country
like Pakistan, there is a need to come up with effective
means of stroke surveillance in order to measure the true
burden of this devastating condition.
We do not know how well do stroke symptoms identi-
fied through CHW-administered questionnaires correlate
with assessment of stroke by a neurologist based on his-
tory and physical exam. SSQs have thus far not been
validated against objective measures in Pakistan.
If community workers can be shown to effectively
screen and identify community dwelling stroke cases,
larger community programs can be implemented and
interventions can be planned.
We thus initiated this study with the objective to trans-
late, adapt, and validate a SSQ for identification of
stroke symptoms by CHW in a periurban Pakistani com-
munity and to determine the feasibility of using such a
tool to assess the prevalence of stroke symptoms in this
community.
Methods/Design
Study Design
In this validation study, criterion validation of a SSQ
and its administration by CHWs will be done. The gold
standard we are using is the assessment by two neurolo-
gists based on history and physical exam. In case of a
discrepancy in the assessment of the two neurologists, a
third neurologist will evaluate the participant, and this
third assessment will be considered final. The inter-
CHW agreement will be assessed by having the same
subject evaluated by both CHWs.
In addition, based on the community-worker-adminis-
tered questionnaire, we also aim to determine the preva-
lence of stroke symptoms in the validation community
using a cross-sectional design.
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Study Setting
Karachi, the largest city of Pakistan, has a population of
23.5 million with a population density of 6,000 people
per square kilometer. There are five administrative dis-
tricts that are further divided into 18 towns. Our study
setting is the Bin Qasim Town, located in the southeast-
ern part of Karachi along the Arabian Sea and the Indus
River delta. This study is being carried out at Ibrahim
Hyderi, a periurban settlement of Karachi, which is one
of the seven union councils of Bin Qasim Town. Ibra-
him Hyderi has a population of 150,000. There are sev-
eral ethnic groups in Ibrahim Hyderi, although the com-
munity is predominantly Sindhi in origin. Over 99% of
the population is Muslim. The neighborhood is focused
on the fishing industry.
The Aga Khan University has been actively involved in
various health projects at Ibrahim Hyderi. In recent past,
AMAN foundation has also started a community health
project in the area. They have mapped a population of
50,000 people spread over 32 small neighborhoods,
called “paras.” We have collaborated with the AMAN
foundation for this project.
Inclusion and Exclusion Criteria
Participants
All permanent residents of the community are eligible
for inclusion if they are above 40 years of age, willing to
participate in all components of the study, (that is CHW
interview and neurologists’ assessment) and can answer
for themselves or have a surrogate willing to provide
necessary information. Surrogate is defined as one who
has lived in the same household as the individual, who
was the primary caregiver and had access to the medical
record / information of the patient. As this is a validation
study, individuals refusing to participate in any of its
components will be excluded from the study.
Chw
Two CHWs, one male and one female, will be recruited
from this community. Their minimum educational
requirement is matriculation, which is equivalent to 10
years of education. They should have no medical back-
ground, since we want our training to have a greater
generalizability.
Neurologist
Two neurologists will evaluate each subject in the vali-
dation part of the study. Both are required to have com-
pleted training in the faculty of neurology with a post-
graduate degree. A third neurologist may be needed in
case of a difference in evaluation of two primary neurol-
ogists. Similar qualifications are required for this person
as well.
Figure 2.  Conceptual framework showing different methods of stroke evaluation.
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Study Team
The study team consists of a principal investigator (PI)
—a neurologist by training, two CHW, one field super-
visor, and one other neurologist.
PI will be responsible for recruitment and training of
CHW and field supervisor. In addition, she will also
conduct neurological assessments for the validation part
of the study. CHW will be responsible for door-to-door
data collection. Field supervisor will be responsible for
overseeing data collection at the field site and will
ensure completeness and accuracy of data. Second neu-
rologist will be responsible for neurological assessments
for the validation part of the study.
Data Collection Tool
Translation and Adaptation of the SSQ
The QVSFS exists in English language. It has six com-
mon stroke symptom questions. An additional question
regarding sudden onset facial weakness was added to it,
and a single question on physician diagnosis of stroke is
maintained. The question regarding TIA is being exclu-
ded as we do not expect understanding of this condition
to exist in our community. Culturally, relevant pictures
have been developed to assist understanding of the
stroke symptom questions (See Additional file 2).
The questionnaire has been translated into Urdu by the
primary investigator, who is also a practicing neurolo-
gist, so that the medical terminologies that are pertinent
to the local setting can be used. This questionnaire has
also been back translated to ensure clarity, by two bilin-
gual individuals, a neurologist and a nonneurologist,
who were asked to give written feedback. No major
issues with clarity were found in this process.
To ensure similar clarity in the field setting, a group dis-
cussion with AMAN’s community workers was held at
their community health center at Ibrahim Hyderi, where
they were given a brief overview of the project. We plan
to conduct a field test, where 30 forms will be distrib-
uted among those who have volunteered to test this
questionnaire for us. They will be asked to collect data
and give feedback regarding clarity of questions and any
other difficulties encountered in the process of data col-
lection. In a second meeting with these workers, verbal
feedback on the questionnaire’s performance will be
taken and any amendments will be incorporated if and as
suggested.
Components of the Tool
1. Questionnaire for CHW: consisting of six
sections.
• Section 1 and 2: Demographic informa-
tion. This includes subject identification
(ID), household number, name, age and
gender of the subject, date and time of
interview, ethnicity, language spoken at
home, education, nature of work, and few
questions related to socioeconomic status.
• Section 3: Stroke symptom question-
naire. This includes eight questions related
to stroke symptoms experienced in the
past. These are to be explained with the
help of pictures provided. Information will
also be collected on whether the subject
needs more than two clarifications to
answer each question.
• Section 4: Comorbid conditions. Infor-
mation will be collected on self-reported
comorbidities like diabetes, hypertension,
heart disease, hospitalization for stroke and
frequency of physician visits.
• Section 5: Stroke knowledge question-
naire. Sixteen true/false statements con-
cerning knowledge of stroke risk factors,
symptoms, and management will be asked
from the subjects. Option of ‘Do not know’
is also given.
• Section 6: Feasibility questions. This sec-
tion enquires about the number of stroke
symptom questions requiring more than
two clarifications and the time it took to
complete the questionnaire.
2. Questionnaire for Neurologist: A structured
questionnaire has been developed for the Neu-
rologist’s assessment, so as to standardize the
history and physical examination carried out by
the two study neurologists.
An additional file contains the questionnaires for CHW
and Neurologists (See additional file 2)
Recruitment and Training of CHW
Two CHW, one male and one female, will be hired for
the purpose of data collection using the eligibility crite-
ria. A manual has been developed to standardize the
training of the CHWs. This manual contains information
regarding the objectives of the study, the job description
of the CHW, pathophysiology, symptomatology and
diagnosis of stroke, as well as instructions on how to
approach subjects and handle refusals in the community.
(See additional file 1 for manual of Instructions)
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A two day workshop will be conducted by the PI. In this
workshop, the CHW will be introduced to basic infor-
mation about stroke in a didactic session. Pictures and
videos will be used to explain various aspects.
The questionnaire will then be explained in detail and
the PI will demonstrate the administration of questions
with the help of pictures, which will further be polished
through role playing. Any queries shall be addressed.
Pilot Phase
A pilot phase will involve administration of around 10
questionnaires. This will ensure elimination of mistakes
prior to formal data collection. After data collection is
complete, data will be checked for sensitivities and spe-
cificities against each CHW and if required CHWs will
be retrained and data will be recollected on a sample of
few subjects to allow sensitivity and specificity calcula-
tions and to address the specific problems identified for
each CHW.
Sampling Technique
For the validation part of the study, systematic sampling
will be employed. This will be done because we want to
cover most mohallas of Ibrahim Hyderi so as to have
greater generalizability. We hope to recruit subjects on
all days of the week, in order to get male representation,
which is expected to be low on working days due to
their employment commitments.
For the prevalence part of the study, a random list of
households will be drawn from an already available list
and subject will then be selected randomly from all
members in a given household.
Sample Size Estimation
We hypothesize that the CHW-administered stroke
symptom questionnaire has at least moderate agreement
with assessment by neurologist
H0: Ƙ<0.4 and Ha: Ƙ>0.4
For the validation study, using Power Analysis and Sam-
ple Size PASS version 11, a sample size of 322 has been
calculated. For a test of interrater agreement using kappa
statistic, this sample size of 322 subjects achieves 80%
power to detect a true kappa value of 0.55 in a test of
H0: kappa ≤ 0.40 versus Ha: kappa > 0.40 when there
were two categories with frequencies equal to 0.21 and
0.79. This power calculation was based on a significance
level of 0.05. The value of kappa = 0.4 is taken as it is
the lower accepted limit for moderate agreement [35]. A
15% change above this is taken as our alternative
hypothesis, which is very close to the value of kappa
reported by the only other validation study of this nature
[27]. The frequencies of 0.21 are taken based on the
prevalence data available from the only community-
based study from Karachi [15].
For the secondary objective of the study to determine the
prevalence of stroke symptoms in the community Open
Source Epidemiologic Statistics for Public Health
(OpenEpi) software version 2.3.1 was used. For preva-
lence of stroke symptoms in a population of 50,000 indi-
viduals, using a 95% confidence level, 21.8% estimated
stroke symptom prevalence reported previously (from a
similar stroke symptom based community study); and
3% bound of error, a required sample size of 718 partici-
pants has been calculated.
Study Procedure
Duration of three months is scheduled for the data col-
lection on 322 subjects for validation part of the study.
A CHW will approach the eligible participant and per-
form required assessment. Within two weeks of being
assessed by a CHW, the participant will be reassessed
by the second CHW. Within one to three weeks of CHW
assessment, the participant will be evaluated by two neu-
rologists on the same day.
Figure 3 demonstrates the flow of the study. The time
between any two evaluations will be kept as minimum
as possible so that any new event could not affect the
validity of the study.
Data Quality Management
Each subject will be assigned a unique three-digit ID,
which they shall be required to reproduce at all subse-
quent evaluations. All data will be kept under lock and
key at all times. Once entered, data will be identified
only with the unique ID.
Statistical Analysis
Statistical analysis will be performed using the SPSS
version 19.0 for Windows (SPSS Inc., Chicago, IL,
USA). Descriptive statistics will be calculated for all
demographic variables. For categorical variables like
gender, income, comorbid conditions etc. frequencies
with proportions will be calculated. For continuous vari-
ables, like age and time taken to fill questionnaire, data
will be reported as mean with standard deviation.
We aim to calculate stroke symptom prevalence as the
proportion of people with a positive stroke symptom
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questionnaire (SSQ will be considered positive even if
response to one item out of eight is in the affirmative).
The sensitivity, specificity, positive, and negative pre-
dictive values with 95% confidence interval will be cal-
culated by comparing the questionnaire responses with
the assessment by a neurologist, which was the gold
standard in the study.
Sensitivity, specificity, and predictive values will be cal-
culated for the questionnaire overall and for each item
singly. Cohen’s kappa coefficient will be used to assess
the level of agreement between the questionnaire and
neurological assessment and between the two CHWS.
95% confidence interval and p value will be reported for
kappa.
Sensitivity analysis will also be done to assess how the
questionnaire behaves across the categories of age, gen-
der, education, and socioeconomic strata.
Ethical Considerations
The study protocol has been approved by the Ethical
Review Committee (2331-CHS-ERC-12). No financial
incentives will be provided to any study participant.
Written informed consent and verbal assent will be
given by all participants or their surrogate prior to the
interview. Those individuals identified as having stroke
on neurological evaluation will be given appropriate
medical advice by the study neurologists and referred to
a tertiary care center if necessary.
Discussion
To the best of our knowledge, this is one of the first
comprehensive community-based validation studies on
stroke symptom questionnaire from South Asia, a region
that harbors 20% of the world’s stroke population.
Training local people in their language will allow recog-
nition and early seeking of health care. Once validated,
such CHW-administered questionnaires can serve as
effective tools for screening large populations for this
devastating condition.
List of Abbreviations Used
NCD Non Communicable Disease
CHD Coronary Heart Disease
TIA Transient Ischemic Attack
WHO World Health Organization
ACAS Asymptomatic Carotid Atherosclerosis
Study
Figure 3.  Study procedure and flow.
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QVSFS Questionnaire for Verifying Stroke Free
Status
CHW Community Health Worker
IHPP Isfahan Healthy Heart Program
CT Computerized Tomography
MRI Magnetic Resonance Imaging
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